Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 532 (RNA5SP532) is a member of the 5S ribosomal RNA pseudogene family. As a pseudogene, it is a DNA sequence similar to the functional 5S ribosomal RNA gene but is non-functional due to mutations or alterations that prevent it from being transcribed or processed into a functional RNA molecule. Pseudogenes like RNA5SP532 are not translated into proteins and do not participate in known biological functions such as signal transduction or cellular metabolism. Therefore, it is not considered a therapeutic target and has no established clinical significance, disease associations, drug interactions, or notable roles in human health or disease. This sequence is catalogued mainly for genome annotation and evolutionary studies. Pseudogenes of 5S ribosomal RNA are abundant in the human genome but do not contribute to ribosome function or gene regulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 532 (RNA5SP532).